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Abstract
Background: FGF signaling has multiple roles in regulating processes in animal development, including the specification
and patterning of the mesoderm. In addition, FGF signaling supports self renewal of human embryonic stem cells and is
required for differentiation of murine embryonic stem cells into a number of lineages.
Methodology/Principal Findings: Given the importance of FGF signaling in regulating development and stem cell
behaviour, we aimed to identify the transcriptional targets of FGF signalling during early development in the vertebrate
model Xenopus laevis. We analysed the effects on gene expression in embryos in which FGF signaling was inhibited by
dominant negative FGF receptors. 67 genes positively regulated by FGF signaling and 16 genes negatively regulated by FGF
signaling were identified. FGF target genes are expressed in distinct waves during the late blastula to early gastrula phase.
Many of these genes are expressed in the early mesoderm and dorsal ectoderm. A widespread requirement for FGF in
regulating genes expressed in the Spemann organizer is revealed. The FGF targets MKP1 and DUSP5 are shown to be
negative regulators of FGF signaling in early Xenopus tissues. FoxD3 and Lin28, which are involved in regulating pluripotency
in ES cells are shown to be down regulated when FGF signaling is blocked.
Conclusions: We have undertaken a detailed analysis of FGF target genes which has generated a robust, well validated data
set. We have found a widespread role for FGF signaling in regulating the expression of genes mediating the function of the
Spemann organizer. In addition, we have found that the FGF targets MKP1 and DUSP5 are likely to contribute to the
complex feedback loops involved in modulating responses to FGF signaling. We also find a link between FGF signaling and
the expression of known regulators of pluripotency.
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Introduction
Fibroblast growth factors (FGFs) are small polypeptides that
have multiple functions in early development and homeostasis of
the adult organism. FGFs are present in all animal groups and are
one of relatively few families of extracellular signaling molecules
that are involved in regulating animal development. 22 FGFs have
been identified in higher vertebrates [1].
FGF signaling has a key role in specifying the primary germ
layers that give rise to all the tissues of the adult organism.
Experiments initially carried out in amphibians, and later
supported by studies in mammals, birds and fish, demonstrated
that FGF signaling is required to regulate gene expression within
the early vertebrate mesoderm, which is the germ layer giving rise
to muscle, skeleton, connective tissue, blood and organs such as the
kidney [2–6]. As well as regulating mesodermal gene expression,
FGF signaling is involved in regulating the complex morphoge-
netic activity exhibited by mesoderm cells during vertebrate
gastrulation [3,7]. FGF signals produced by the mesoderm, acting
on the adjacent ectoderm, are also required for induction and
patterning of the vertebrate nervous system [8–11].
More recently it has been shown that FGF signaling plays a
critical role in the commitment of mouse embryonic stem (ES) cells
to mesodermal, as well as both neural and non-neural ectodermal
lineages [12,13]. FGF signaling is also important for maintaining
self renewal in human ES and induced pluripotential stem (iPS)
cells in culture [14–16].
Given the importance of FGF signaling in adult and embryonic
life, the downstream transcriptional targets involved in mediating
the activities of the FGFs are of great interest. In order to identify
genes that respond to FGF signaling in early development we have
compared gene expression in normal embryos with embryos in
which FGF signaling has been inhibited. Our analysis identifies 67
genes which are significantly down regulated and 16 genes which
are up regulated in response to FGF inhibition. A high proportion
of the putative FGF target genes have predicted functions
associated with cell signaling and transcriptional regulation.
We show that many of the targets are expressed in known
regions of FGF activity during development. Our analysis reveals
some interesting features of the FGF dependent transcriptome. We
find that FGF signaling is required for the normal expression of
multiple genes in the Spemann organizer, a structure orthologous
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establishment of the main body axis.
Intrestingly, we find that inhibition of FGF signaling down
regulates expression of Lin28 and FoxD3, two genes which have
been implicated in regulating the pluripotential state of embryonic
stem (ES) cells [14,17–19].
Cluster analysis, based upon temporal expression, identified a
number of distinct waves of expression from FGF targets following
the initial activation of FGF signaling in the amphibian embryo.
Following the activation of endogenous FGF signalling in blastula
stages, we show that two of the earliest expressed target genes are
the MAP kinase phosphatase 1 (MKP1) gene and a novel Xenopus gene
related to human Dual Specificity Phosphatase 5 (DUSP5). We show
that both DUSP5 and MKP1 inhibit FGF dependent ERK/MAP
kinase phosphorylation and mesoderm formation induced by FGF
in Xenopus tissues. Our analysis indicates that DUSP5 and MKP1
are members of the FGF synexpression group and are components
of the negative feedback network required to limit the extent of
FGF signaling in the early embryo.
Results
Timing of FGF signaling in the Xenopus embryo
The aim of this study was to identify FGF targets that are
induced shortly after the initial activation of zygotic FGF signaling
in the embryo. It was therefore necessary to accurately determine
when FGF signaling is activated in the embryo. We examined the
temporal profile and spatial distribution of activated diphospho-
ERK (dp-ERK), which is a key signal transduction effector of FGF
signaling in the Xenopus embryo [20–22]. Figure 1A is a Western
blot showing levels of dp-ERK in embryos from early cleavage to
late blastula stages (NF stage 3 to 9.5). We detect constant low
levels of activated ERK up to stage 8.5. The initial rise in the level
of dp-ERK is detected at mid-blastula stage 8.5 and there is robust
increase by stage 9 (7 hours post-fertilization (pf) at 23uC),
corresponding to the onset of major zygotic transcription at the
mid-blastula transition (MBT) [23].
Our data show that the initial activation of ERK is in a dorsal to
ventral gradient within a broad belt of tissue around the equator of
the embryo at late blastula stage 9 (Figure 1B). Initial dp-ERK
activation is not limited to the presumptive mesoderm of the
marginal zone but extends a considerable distance into the animal
hemisphere on the dorsal side of the embryo. Figures 1C and D
show that this early zygotic ERK activity is blocked by over
expression of a dominant negative FGF receptor (dnFGFR). The
dnFGFRs used in this study are carboxy-terminal truncations of
the receptors lacking tyrosine kinase activity and block FGF
signaling by associating with endogenous receptors to form non-
functional dimers [24,25]. We conclude that zygotic activation of
the FGF signaling pathway commences at mid-blastula stage 8.5
(6 hours pf at 23uC).
Timing of transcriptional responses to FGF signaling in
the Xenopus embryo
The genes coding for the brachyury, MyoD and Cdx4
transcription factors have previously been identified as targets of
the FGF signaling pathway. These genes are activated by FGF
even in the presence of the translation inhibitor cycloheximide and
are defined as immediate early responses to FGF signaling [26–
28]. We have used expression of these genes to indicate when the
initial transcriptional responses to FGF signaling occur in the
Xenopus embryo. Figure 1E is an RNAase protection analysis
(RPA) showing that Brachyury expression is detected by early
gastrula stage 10 and Cdx4 by stage 10.25. However, robust
expression of all three immediate early FGF response genes is not
detected until stage 10.5 (11 hours pf at 23uC). Furthermore, we
show that the initial expression of all three genes is blocked by over
expression of a dnFGFR. Based on the timing of ERK activation
and transcriptional activation of known FGF target genes, early
gastrula stage 10.5 (11 hours of culture at 23uC) was chosen as the
stage for the analysis of FGF targets.
Identifying transcriptional responses to FGF signaling
In order to identify transcriptional targets of FGF signaling gene
expression in control embryos was compared to sibling embryos in
which FGF signaling was inhibited by over expression of dominant
negative versions of FGFR1 (dnFGFR1) or FGFR4 (dnFGFR4)
[24,25].
In order to undertake statistical analysis of the microarray data
three biological replicates were carried out. Each replicate set
consisted of control embryos and embryos injected with dnFGFR1
or dnFGFR4 collected at stage 10.5 (11 hours pf at 23uC). Before
proceeding to microarray analysis each replicate set was checked
for effective FGF inhibition. Sibling embryos from each replicate
set were analysed for dp-ERK levels and expression of Cdx4,
Brachyury and MyoD by both RPA and in situ hybridization.
Figures 1F–1H are analyses of a representative biological replicate
set showing that, with the experimental conditions used,
overexpression of dnFGFR1 or dnFGFR4 results in potent
inhibition of ERK activation (Figure 1F) and down regulation of
transcription from known FGF target genes relative to sibling
controls (Figures 1G and 1H).
Changes in gene expression resulting from dnFGFR1 and
dnFGFR4 overexpression
After these quality control checks, the RNA samples from each
of the three biological replicates were analysed using Affymetrix
GeneChip Xenopus laevis Genome Arrays, which allow the analysis
of more than 14,400 transcipts expressed in early development.
Figures 2A and 2B are scatterplots of log2 gene expression values
in controls versus dnFGFR1 and dnFGFR4 injected embryos.
Probe sets showing greater than 2-fold changes of expression in
control versus experimental groups are indicated by red and green
points. These data show that the expression of a considerable
number of genes is altered in response to FGF inhibition by both
dnFGFR1 and dnFGFR4.
In contrast to Figure 2A and 2B, in dnFGFR1 versus dnFGFR4
injected embryos we see that expression levels of relatively few
probe sets are greater than two-fold different between the two
groups (Figure 2C). Our analysis shows that only four genes, using
the criteria of $2-fold change in expression and a significance
level of p#0.01, exhibit different expression levels in dnFGFR1
versus dnFGFR4 injected embryos (Table S1). This indicates that
at this stage of development the genes affected by inhibition with
the different dominant negative receptors are largely the same.
The differences in gene expression profiles of dnFGFR1 and
dnFGFR4 injected embryos are quantitative differences in the
levels of expression from the same set of target genes. This
conclusion is supported by Figure 2D, which shows that both
dnFGFR1 and dnFGFR4 down regulate the expression of several
known FGF targets. However, in all cases dnFGFR4 has a more
potent effect on gene expression. The data in Figure 2A and 2B
follow a similar trend, in which there are greater fold changes in
gene expression following dnFGF4 injection than with dnFGFR1.
We conclude that inhibition with dnFGFR1 and dnFGFR4 affects
the same sets of genes but that on a per mass of injected mRNA
basis, dnFGFR4 is more potent.
FGF Target Genes in Xenopus
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Lists of genes affected by FGF inhibition were compiled by
comparing gene expression changes in dnFGFR4 injected
embryos versus control embryos. The criteria of at least a 2-fold
change in expression and a significance level of p#0.01 were used
to compile the gene lists. After the elimination of multiple probe
sets representing the same gene, using the stated criteria, we find
that 67 genes are significantly down-regulated by FGF inhibition,
indicating that in normal development these genes are positively
regulated by FGF signaling. Table 1 shows these genes in order of
mean fold inhibition in dnFGFR injected embryos relative to
controls. The T-box gene brachyury shows the highest fold
inhibition (.19-fold). We find that only 16 genes are significantly
up-regulated by FGF inhibition, indicating that in normal
development these genes are negatively regulated by FGF
signaling (Table 2).
Where possible we have classified FGF target genes based on
cellular function. We find that a large proportion of genes
positively regulated by FGF signaling are either involved in
transcriptional regulation (24%) or cell signaling (18%), with a
Figure 1. FGF signaling in early development. (A) is a Western blot showing levels of diphospo-ERK (dp-ERK) in whole embryos from cleavage
stage 6 to late blastula stage 9.5 (3 to 8 hours pf at 23uC). GAPDH is a ubiquously expressed loading control. (B) shows whole mount
immunohistochemistry for dp-ERK in blastula stage 9 embryos. In animal hemisphere view dorsal side is to the right. In lateral view the animal
hemisphere is to the top and the dorsal side is to the right. In dorsal view the animal hemisphere is to the top. (C) is a Western blot comparing dp-ERK
levels in control uninjected embryos and embryos injected with 4 ng dnFGFR4 mRNA from blastula stage 9 to early gastrula stage 10.25. (D) shows
whole mount immunohistochemistry for dp-ERK at blastula stage 9 in a control uninjected embryo and an embryo injected with 4 ng dnFGFR4
embryo. Embryos are viewed from the animal hemisphere with dorsal side to the right. (E) is an RNAase protection analysis (RPA) showing the
expression of Cdx4, MyoD, brachyury and ODC in control uninjected embryos and embryos injected with 4 ng dnFGFR4 mRNA from early gastrula
stage 10 until stage 10.5. ODC is a ubiquioulsy expressed loading control. 10 mg of total RNA were used per hybridization. (F) is a Western blot
showing dp-ERK levels in control uninjected embryos, embryos injected with 4 ng dnFGFR1 mRNA and embryos injected with 4 ng dnFGFR4 mRNA
at early gastrula stage 10.5. The embryos are siblings to one set of the three biological replicates used for the microarray analysis. (G) is an RPA
showing expression of Cdx4, MyoD and brachyury in control uninjected embryos, embryos injected with 4 ng dnFGFR1 mRNA and embryos injected
with 4 ng dnFGFR4 mRNA at early gastrula stage 10.5. The embryos are siblings to one set of the three biological replicates used for the microarray
analysis. (H) shows whole mount in situ hybridizations for Cdx4, MyoD and brachyury in control uninjected embryos , embryos injected with 4 ng
dnFGFR1 mRNA and embryos injected with 4 ng dnFGFR4 mRNA at early gastrula stage 10.5. The embryos are siblings to one set of the three
biological replicates used for the microarray analysis.
doi:10.1371/journal.pone.0004951.g001
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of metabolism. The corresponding figures for genes negatively
regulated by FGF signaling are 29% involved in transcriptional
regulation, 6% in cell signaling and 29% in metabolism. These
data are represented as pie charts in Figure 2E and the detailed
breakdown of FGF target classification, together with relevant
references are presented in Tables S2, S3, S4, S5, S6, S7, S8, S9,
S10 and S11. Tables S12 and S13 show the Gene Ontology (GO)
term classifications for FGF targets derived from the available
Affymetrix annotation files.
Expression of FGF target genes
Consistent with the pattern of FGF activity in the late blastula
and early gastrula stage embryo (Figure 1) many of the genes
identified as being down regulated following FGF inhibition are
expressed in the mesoderm or dorsal ectoderm at the start of
gastrulation. Expression data for previously characterised genes,
along with new data from this study are summarized in Table S14.
We have undertaken a more detailed expression analysis of a
number of these positively regulated FGF targets at early gastrula,
early neurula, post-neurula and early tailbud stages. (Figure 2F)
We find that all of these genes are expressed in the mesoderm
around the mesoderm. In post-gastrula stages the expression
patterns of these genes diversify; however, some common patterns
are detected. For example, the posterior mesoderm, the paraxial
mesoderm and the tailbud are common sites of expression. Other
sites of expression include the anterior CNS and branchial arches.
In the case of a putative methyltransferase the post-gastrula
expression is remarkably restricted, being limited to a very tight
domain around the closed blastopore and later in the developing
otic vesicle.
The expression patterns were also determined for two of the
genes that are up regulated in response to FGF inhibition, which
we predict will be negatively regulated by FGF signaling in normal
development (Figure 2G).
Wig-related codes for a protein similar to Xwig1, which is a
putative endoplasmic reticulum resident protein [29]. GILZ
(glucocorticoid inducible leucine zipper), is a member of the
Tsc-22 family of transcription factors related to Drosophila bunched
[30]. In contrast with genes positively regulated by FGF, the early
expression of these genes is excluded from the circum-blastoporal
region. The Wig-related gastrula and post-gastrula expression
pattern is highly dynamic, before resolving to a stable pattern of
expression in the CNS, branchial arches and lateral mesoderm.
After gastrulation GILZ is expressed in the neurogenic region of
the open neural plate and subsequently in the neural tube.
Validation of FGF targets
It is generally accepted that gene lists identified by microarray
analysis should be validated by independent methodology. For a
number of the putative target genes independent validation of
their response to FGF signaling was undertaken by in situ
hybridization. Figure 3A shows the effects of FGF inhibition on the
spatial expression of genes identified as being down regulated in
the microarray-based screen. Injection of dnFGFR leads to
dramatic inhibition of the circum-blastoporal expression of these
genes in gastrula stage embryos.
Conversely, the size of the expression domains of two putative
targets negatively regulated by FGF signaling are dramatically
increased in embryos injected with dnFGFR mRNA (Figure 3B).
In the case of CP2-like and GILZ, inhibition of FGF signaling
leads to elevated expression in the circum-blastoral region
indicating that in normal development FGF signaling is required
to exclude their expression from this region of the embryo.
Further validation of the FGF target genes was undertaken by
showing that FGF signaling is not only necessary but is also
sufficient for their expression. Figure 3C shows an RNAase
protection assay (RPA) on control animal hemisphere tissue
explants (animal caps) and animal caps treated with recombinant
FGF4 protein. With all genes tested, FGF treatment leads to
marked increase in transcription as compared to control explants.
Taken together, our analyses indicate that the microarray based
screen has provided a well supported list of candidate FGF target
genes.
FGF signaling and dorsal gene expression
The identified FGF target genes included several genes,
including chordin and noggin, which are required for the function
of the Spemann organizer in the dorsal mesoderm [31,32]. This
region of the embryo plays a key role in regulating the formation
of the main body axes. We investigated if there is a general role for
FGF in regulation of dorsal gene expression. The data in Data in
Figure 4A and Table 3 show that many dorsally biased genes,
including Egr1 and FoxD5 are highly down regulated when FGF
signaling is inhibited (.12-fold and .10-fold respectively). Many
of the dorsally expressed FGF target genes have been shown to be
directly involved in mediating organizer function, including Frzb1,
chordin, noggin, FoxD3, FoxD5 and goosecoid. Other dorsally expressed
genes, such as Xnr3 and cerberus, are not significantly down
regulated, and others such as Otx2 show small increases in
expression (not significant at the p=0.01 level).
The in situ hybridizations in Figure 4B show that FGF inhibition
dramatically reduces the spatial extend of chordin, FoxD5 and Frzb
expression through early gastrula stages. We also show by RPA
that chordin and noggin are strongly down regulated in early gastrula
stage embryos following FGF inhibition (Figure 4C), indicating a
role for FGF in regulating the expression of secreted BMP
inhibitors.
Stimulation of BMP signaling leads to the phosphorylation and
activation of SMAD1. Figure 4D is a Western blot for phospho-
Figure 2. Identification of FGF target genes. (A, B and C) are scatterplots of log2 probeset expression values from the Affymetrix microanalysis
undertaken on early gastrula stage 10.5 control embryos, dnFGFR1 injected embryos and dnFGFR4 injected embryos . Values for each point are the
average of three biological replicates. The centre line represents a ratio of 1:1 between the two groups indicating no difference in expression. The
outlying lines represent two fold differences in expression. Points representing probe sets showing $2 reduction in expression are indicated in green.
Points representing probesets showing $2 increase in expression are indicated in red. (D) is a chart showing the expression of brachyury (bra), cdx4,
marginal coil (M.coil), Iro3 and sprouty2 in control embryos and embryos injected with 4 ng dnFGFR1 mRNA or 4 ng dnFGFR4 mRNA. Microarray
derived expression values are based on the average of three biological replicates. Relative expression is calculated as a percentage of the expression
in control embryos. Standard deviation bars are indicated. (E) shows pie charts of genes positively and negatively regulated by FGF signaling.
Percentages of each group classified according to their putative cellular function are indicated. Details of the up regulated and down regulated genes
are contained Tables 1, 2 and Tables S2 to S11. (F) shows the expression patterns of genes positively regulated by FGF signaling at determined by in
situ hybridization at early gastrula stage 10.5, early neurula stage 14, post-neurula stage 22 and early tailbud stage 30. Gastrula embryos are vegetal
views with dorsal to the top. Neurula embryos are dorsal views with anterior to the left. Post-neurula and tailbud embryos are lateral view with dorsal
to the top and anterior to the left. (G) shows the expression patterns of genes negatively regulated by FGF signaling.
doi:10.1371/journal.pone.0004951.g002
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Gene Fold inhibition GenBank accession Affymetrix probe set
Brachyury 19.2 M77243 Xl.514.1.S1_at
Egr1 12.4 AF250345 Xl.637.1.A1_at
FoxD5A 10.8 AF162782 Xl.642.1.S1_at
SIP1 9.8 AB038353 Xl.958.1.S2_at
Cdx4 8.6 UO2034 Xl.10269.1.S1_at
Esr5 8.5 BJ057112 Xl.14524.1.S1_at
Purine phosphorylase 7.9 BM172525 Xl.16206.1.A1_at
Marginal coil 7.7 BJ044312 Xl.5454.1.S1_at
Paraxial protocadherin 7.3 AW782445 Xl.6173.1.A1_at
Glycogen phosphorylase 7.0 BJ056085 Xl.7815.1.A1_at
NADH dehydrogenase sub-unit 6.5 BJ051675 Xl.12993.1.A1_at
FoxD3A 6.0 AB014611 Xl.525.1.S1_at
G-coupled receptor P2Y5 5.7 BQ401062 Xl.19933.1.S1_at
Related to DC-STAMP domain receptor 5.6 BI447679 Xl.15270.1.A1_at
Meso05 5.1 BF615090 Xl.7720.1.A1_at
Uncharacterised protein C2orf32 5.1 CB756627 Xl.25136.1.A1_at
Frzb1 5.1 U78598 Xl.212.2.S1_a_at
XPO 5.0 BJ051206 Xl.5908.1.S1_s_at
Ephrin receptor A4 4.8 BJ080037 Xl.13.2.A1_at
XSpr2 4.5 BJ049843 Xl.2755.1.S1_a_at
Zic3a 4.5 AB005292 Xl.7969.1.S1_at
Xiro3 4.4 AF027175 Xl.4522.1.S1_at
Gravin-like 4.4 AF308810 Xl.3468.1.S1_at
Alkaline phosphatase 4.3 BC043760 Xl.1299.1.S1_at
Apobec2 4.2 AW766385 Xl.5876.1.A1_a
p75-like fullback receptor 4.2 AF131890 Xl.3540.1.S1_at
Wnt8 4.0 X57234 Xl.49.1.S1_at
Fructokinase-related protein 3.9 CB756273 Xl.15623.1.A1_at
Crescent 3.9 AF260729 Xl.619.1.S1_at
Pinhead 3.8 BJ056268 Xl.3529.1.A1_at
Wnt5b 3.6 AW148258 Xl.11619.1.S1_at
Unknown 3.6 BJ092401 Xl.5479.1.A1_at
Retrotransposon protein 1a11 3.6 L11263 Xl.3352.1.S1_at
FoxA4 3.4 S93559 Xl.1082.1.S1_at
Mitotic phosphoprotein 67 3.2 BJ077239 Xl.20772.1.A1_at
Cdx1 3.2 CB564190 Xl.23739.1.A1_at
Sprouty2 3.1 AF331825 Xl.11965.1.S1_at
DUSP5 3.0 BJ077463 Xl.15374.1.A1_at
Chordin 2.8 BF610870 Xl.3549.1.S1_at
MKP1 2.7 AJ320159 Xl.2803.1.S1_at
Unknown 2.7 BI312705 Xl.18179.1.S1_at
Xom 2.7 X98454 Xl.37.1.S1_at
Putative nucleolar GTP binding protein 2.7 BM179370 Xl.14776.1.A1_at
Lin28a homologue 2.7 BJ047699 Xl.3418.1.A1_at
Glut1 transporter 2.7 BJ049047 Xl.24121.1.A1_at
Unknown 2.6 BJ056692 Xl.15382.1.A1_at
Dkk1 2.6 AF030434 Xl.251.1.S1_at
Unknown 2.5 AW460550 Xl.11594.1.A1_at
RALDH2 2.5 BI449483 Xl.18999.1.A1_at
Prickle 2.5 AF387815 Xl.7556.1.S1_at
FGF Target Genes in Xenopus
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in regulating dorsally expressed secreted BMP inhibitors, such
chordin and noggin, levels of p-SMAD1/5/8 are elevated in
response to FGF inhibition. Our data indicate a widespread but
not ubiquitous requirement for FGF signaling in the regulation of
organizer gene expression during gastrula stages.
Expression profiling and cluster analysis of FGF target
genes
In order to generate temporal expression profiles for individual
FGF target genes from pre-MBT stages until early neurula stages
we carried out Affymetrix microarray analysis on normally
developing sibling embryos at hourly time points from 5 hours
pf (stage 8) to 16 hours pf (stage 14) at 23uC.
Figure 5A shows the relative expression profiles of FGF8 and 5
known FGF target genes. The initial rise in FGF8 expression is first
detected at stage 9 (7 hours pf), indicating that FGF8 expression is
activated very rapidly post-MBT. As mentioned earlier, this
increase in FGF8 expression corresponds closely with the detected
rapid elevation of dp-ERK levels in the embryo between stage 8.5
and stage 9 (Figure 1A). We note that although normal expression
of these genes requires FGF signaling, the timing of gene
Gene Fold inhibition GenBank accession Affymetrix probe set
ADMP 2.4 BF231842 Xl.3809.1.A1_at
Unknown 2.3 BJ085271 Xl.1521.1.A1_at
Cytochrome B561 2.3 U16364 Xl.11917.1.S1_at
Goosecoid 2.3 BJ056432 Xl.801.1.S1_at
FoxC1 2.3 AF116844 Xl.180.1.S1_at
Noggin 2.2 M98807 Xl.834.1.S1_at
Sprouty1 2.2 BG022481 Xl.10087.1.A1_Fat
Oct1 2.2 BG022051 Xl.1265.1.S1_at
Rexp52 2.1 BG555868 Xl.3023.1.A1_at
Grb10 interacting protein2 2.1 BJ098841 Xl.14208.1.A1_at
Putative methyltransferase 2.1 BJ100128 Xl.20056.1.S1_a_at
Connexin 29 2.1 BJ076720 Xl.8924.1.A1_at
SMCT 2.1 BJ047968 Xl.6392.1.A1_at
Weakly similar to Rab1 2.1 BJ079872 Xl.3365.1.A1_at
Unknown 2.1 CA972457 Xl.19961.1.S1_at
Moderately similar to Brain protein 44 2.1 BJ088835 Xl.15887.1.S1_x_at
Ephrin receptor A2 2.0 BF025525 Xl.14496.1.A1_at
doi:10.1371/journal.pone.0004951.t001
Table 1. cont.
Table 2. Genes negatively regulated by FGF signaling.
Gene Fold activation GenBank accession Affymetrix probe set
XIRG protein 13.5 AJ278067 Xl.4965.1.S1_at
PDGF A chain 5.6 M23238 Xl.841.3.S1_a_at
WIG-related 5.3 BJ044287 Xl.23988.1.S1_at
CP2-like transcription factor 4.3 BJ046394 Xl.16094.1.A1_at
Glucocorticoid inducible leucine zipper 4.1 BC043841 Xl.12378.1.S1_at
Unknown 3.8 AW147865 Xl.2077.1.A1_at
WIG 3.7 AF310008 Xl.736.1.S1_at
XANF1 3.1 X60099 Xl.131.1.S1_at
HES-related 1B 3.0 AB071434 Xl.12126.1.S1_at
Darmin 2.9 CD324819 Xl.6024.1.S1_at
ODC2 2.8 AF217544 Xl.8949.1.S1_at
Unknown 2.4 AW460608 Xl.11598.1.A1_at
Thioredoxin binding protein 2 2.3 BQ399899 Xl.24749.1.A1_at
Unknown 2.2 BM192746 Xl.25985.1.A1_at
Selenophosphate synthetase 1 2.1 BJ091471 Xl.6522.1.A1_at
Adenosine deaminase 2.1 BJ090126 Xl.24155.1.A1_at
doi:10.1371/journal.pone.0004951.t002
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can be quite different. For example, sprouty2 is expressed at low
levels maternally and the initial rise in levels of zygotic expression
is detected at stage 9.5 which is 1 hour at 23uC after the activation
of FGF8 expression. Subsequently, sprouty2 expression continues to
closely follow that of FGF8 during late blastula stages (stage 9 to
10). The initiation of brachyury and Iro3 expression is somewhat
delayed relative to initiation of FGF signaling, with a slight rise in
expression by stage 9.5 and a more significant increase in
expression by stage 10. Expression from Cdx4 and marginal coil
are even more delayed and their expression levels only begin to
rise steeply from stage 10 onwards.
The differing dynamics of expression from known target genes
indicate that there are different classes of FGF response genes. We
Figure 3. Validation of FGF target genes. (A) shows whole mount in situ hybridizations for genes positively regulated by FGF signaling at
gastrula stage 10.5 in control embryos and embryos injected with 2 ng of dnFGFR1 mRNA. (B) shows the expression gene negatively regulated by
FGF signaling in control embryos and embryos injected with 2 ng dnFGFR1 mRNA. All embryos are vegetal view with dorsal to the top. Non-uniform
down regulation around the circumference of the blastopore is apparent in some embryos and is likely due to variability in the diffusion of injected
dnFGFR mRNA. (C) is an RPA showing the expression at gastrula stage 10.5 of a number of genes in control animal cap explants and explants treated
with FGF4 protein. 5 mg total RNA was used per hybridization. ODC is a loading control.
doi:10.1371/journal.pone.0004951.g003
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dependent genes based upon their temporal expression profiles
from early blastula to early neurula stages. For the generation of
clusters of genes positively regulated by FGF signaling a
correlation value of p$0.85 was used. The cluster analysis of
genes negatively regulated by FGF is not presented because this
group contains considerably fewer genes leading to multiple
clusters containing single genes.
The genes in each of the clusters used for further analysis are
shown in Table 4. The dendrogram generated during cluster
analysis is shown in Figure 5B. Figure 5C shows a heat map of the
relative expression of each of the generated clusters from stage 8 to
stage 14. The expression profiles of the clusters positively regulated
by FGF signaling, together with that of FGF8, are shown in
Figure 5D. In keeping with our findings for individual known FGF
targets, the initiation of expression from each of the clusters relative
to the activation of FGF signaling varies considerably. For example,
activation of expression from genes in clusters #11 and #9 rapidly
follows the activation of FGF8 expression. However, at 23uC
activation of expression from genes in cluster #1i sd e l a y e d2 –
3 hours relative to that of FGF8. Activation of expression from genes
inclusters #7a n d#8 occursat an intermediatetimepoint with a 1–
2 hour lag relative FGF8 and the activation of FGF signaling.
Identification of a novel negative regulator of FGF
signaling
The earliest activation of zygotic transcription from putative
FGF target genes occurs between blastula stage 8.5 to 9. During
this period a number of genes undergo .10-fold increase in
expression. Amongst these rapid responders Dual specificity
phosphatase 5 (DUSP5) has the highest fold increase during this
period (.35). Xenopus laevis DUSP5 codes for a putative MAP
kinase phosphatase with 61% peptide sequence identity to human
DUSP5 (Figure S1).
Expression of another MAP kinase phosphatase, MKP1/
XCL100 [33], is also significantly down regulated in response to
Figure 4. FGF signaling and regulation of dorsal gene expression. (A) is a bar chart showing the log2 of the ratio of expression dnFGFR4
injected embryos versus control embryos for a number of dorsally expressed genes at gastrula stage 10.5. Microarray derived expression values are
based on the average of three biological replicates. Bars in red below the centre line represents genes down regulated in response to FGF inhibition.
Bars in green represent genes up regulated in response to FGF inhibition. (B) shows whole mount in situ hybridizations for chordin, FoxD5 and Frzb in
control embryos and embryos injected with 4 ng dnFGF4 mRNA at very early gastrula stage 10+ and mid-gastrula stage 11. All embryos are vegetal
views with dorsal to the top. (C) is an RPA showing the expression of chordin and noggin in control embryos and embryos injected with 4 ng
dnFGFR1 mRNA at gastrula stage 10.5. (D) is a Western blot showing levels of phospho-SMAD1/5/8 (p-SMAD) at gastrula stage 10.5 in control
embryos, embryos injected with 4 ng dnFGFR1 mRNA or 1 ng mRNA coding for secreted the BMP inhibitor noggin. GAPDH is a loading control.
doi:10.1371/journal.pone.0004951.g004
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Xenopus MAP kinase phosphatase, MKP3, has been shown to
inhibit FGF dependent mesoderm induction [21] and is implicated
as a component of a negative feedback loop regulating FGF
activity in the embryo [34]. Given the critical role that ERK/MAP
kinase activity has in mediating responses to FGF signaling in the
early Xenopus embryo we investigated the potential role of DUSP5
and MKP1 as negative regulators of FGF mediated MAP kinase
signaling in early development.
Figure 6A is a chart showing the temporal expression profiles of
MKP1, MKP3 and DUSP5 as determined by microarray analysis.
Expression of all three MKPs rises rapidly during late blastula
stages, reaching maxima in early gastrula stages. Our data show
that both MKP1 and DUSP5 are expressed in the circum-
blastoporal region of the embryo during gastrula stages
(Figures 2F). MKP3 is also expressed in this region in the gastrula
[34]. In post-gastrula stages MKP1 is expressed in much of the
open neural plate and subsequently in the anterior CNS and
somites (Figure 2F). In contrast, at neurula stages DUSP5 is
expressed in the posterior mesoderm around the closed blastopore
and in a restricted domain in the anterior open neural plate. Later
in development it is expressed in distinct domains in the anterior
CNS, the tailbud and branchial arches.
Figure 6B shows the degree to which expression of the three
MKPs in the early gastrula is down regulated in response to FGF
inhibition with dnFGFR1 and dnFGFR4. Consistent with this,
expression of MKP1 and DUSP5 in the circum-blastoporal region
during gastrula stages is dependent on FGF signaling (Figure 3A).
Similar FGF dependence has been reported for MKP3 [34]. We
also show that FGF signaling is sufficient for MKP1 and DUSP5
expression; treatment of animal cap explants with FGF proteins
leads to marked up regulation of both genes (Figure 3C).
Treatment of animal cap explants from blastula stage embryos
with FGF protein results elongation of the explant and
development of vesicles containing a range of mesodermal tissues.
Figure 6C shows that overexpression of MKP1, MKP3 or DUSP5
inhibits the formation of vesicles, indicating that like MKP3,
MKP1 and DUSP5 are able to block FGF mediated formation of
mesodermal tissues. We have confirmed this by examining
histology of the differentiated tissues in FGF and DUSP5 treated
explants (Figure 6D). Sections of untreated, control explants show
the presence of a mass of atypical epidermis, whereas, FGF treated
explants contain copious mesodermal tissue types, including a
layer of smooth muscle (mesothelium) and loosely packed
mesenchyme. Histology reveals the absence of mesodermal
differentiation in response to FGF treatment when explants are
over expressing DUSP5. Figure 6E shows that treatment of animal
cap explants with FGF4 protein leads to phosphorylation and
activation of ERK/MAP kinase and that over expression of either
MKP1, MKP3 or DUSP5 in animal hemisphere explants
dramatically inhibits FGF induced ERK phosphorylation.
Our data indicate that normal expression of MKP1 and DUSP5
in the early embryo requires a functional FGF pathway and that
MKP3, MPK1 and DUSP5 have similar abilities to negatively
regulate FGF signaling.
Discussion
FGF signaling in the early embryo
There is a wealth of evidence indicating that FGF signalling is
involved in regulating multiple developmental processes before
and during amphibian gastrulation [1,35]. FGF dependent
regulatory pathways have been shown to operate at different
levels within the cell. For example, FGF signal transduction
involving PKC and Ca++ modulates the planar cell polarity
pathway necessary for the morphogenetic movements of gastru-
lation [36]. Another key function of FGF signalling during gastrula
stages is as a regulator of gene transcription and it is this latter
function which is the focus of the present study.
Identification of transcriptional targets of FGF signaling
Our study was designed to identify early transcriptional
responses to FGF signalling. The reagents that we used to inhibit
FGF signaling were dominant negative mutants of FGF receptor 1
(dnFGFR1) and FGF receptor 4a (dnFGFR4a) [24,25]. Over
expression of either dnFGFR1 or dnFGFR4a leads to very similar
effects on gene expression at the start of gastrulation.
Using the strict criteria outlined, we have identified 67 genes
which are down regulated and 16 genes which are up regulated in
response to FGF signaling. The target validation undertaken
indicates that these FGF targets lists are well supported and should
provide the basis for further studies into FGF dependent
transcriptional regulation.
Different waves of FGF dependent gene regulation
As part of this study we carried out a time course analysis of
gene expression from mid-blastula to early neurula stages. Our
Table 3. Effects of FGF inhibition on organizer gene
expression.
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activation of expression from FGF dependent genes occurs in a
number of waves following the mid-blastula transition (MBT).
Some genes are activated very rapidly following the MBT and
closely follow the expression profile of FGF8. Expression of other
genes, including Brachyury and Cdx4, which are known immediate
early response genes, activated by FGF signaling in the absence of
protein synthesis, occurs in later waves [26,37]. At present it is
unclear why some immediate early responses are more rapid than
others. However, we speculate that the presence of identifiable
clusters of FGF response genes indicates that similar upstream
mechanisms are involved in regulating the expression of genes
within the same cluster. The identification of such clusters of co-
expressed transcriptional targets of FGF signaling will allow the
analysis of these genes for shared regulatory elements required to
drive their common modes of expression.
It is important to note that our analysis does not rule out the
involvement of other signaling pathways in the regulation of the
identified FGF target genes. Indeed this is to be expected, given
that FGF signaling has been shown to interact with a number of
pathways regulating gene expression in early development,
including the activin/nodal and Wnt signaling pathways [38–41].
Patterns of FGF target gene expression
The initial zygotic expression of several FGF ligand genes,
including FGF3, FGF4, FGF8 [42–44] and FGF20 (Figure S2) is
restricted to the early mesoderm during late blastula stages. In
keeping with this we find that many target genes positively
regulated by FGF signaling are also expressed in the mesoderm.
Our analysis of FGF dependent gene expression in later
development shows that there is diversity in their later expression.
However, we note that the posterior mesoderm, the paraxial
Figure 5. Cluster analysis of genes down regulated in response to FGF inhibition. (A) shows the temporal expression profiles of FGF8
(dashed line) and several known FGF target genes from blastula stage 8 until early neurula stage 14 (5 to 16 hours pf at 23uC). Profiles are derived
from normalised microarray expression levels. Relative expression values are represented as percentages of the maximum expression value for each
gene. (B) is a cluster dendrogram generated within BRB-ArrayTools for genes that are significantly down regulated in response to FGF inhibition i.e.
positively regulated by FGF signaling. The red line indicates the level at which the dendrogram was cut, corresponding to a correlation coefficient of
0.85. (C) is a heat map of temporal expression for gene clusters positively regulated by FGF signalling. Only clusters containing $5 members are
presented. Values at each time point from blastula stage 8 to early neurula stage 14 are derived from the mean of the expression levels for all the
genes in each cluster. (D) shows the temporal expression profiles of FGF8 and gene clusters positively regulated by FGF signalling based upon the
mean of the expression levels for all the genes in each cluster.
doi:10.1371/journal.pone.0004951.g005
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expression for the FGF target genes. These are all known sites of
FGF activity and ligand expression including FGF3, FGF4 and
FGF8 [22,42–44]. We show that FGF7 and FGF10 are also
expressed in the posterior of the embryo and in the branchial arch
region (Figure S2). An interesting example of the correspondence
of target gene expression with sites of FGF signaling in later
development is seen with a putative methyltransferase gene, which in
tailbud stages is expressed exclusively in the developing otic vesicle
in close proximity to FGF10 expression (Figure S2).
FGF regulation of organizer gene expression
Early studies of FGF function in early amphibian development
focused on their potential role as regulators of gene expression in
the ventro-lateral mesoderm [35,45,46]. However, more recent
studies have provided evidence that FGF signaling is also required
for the expression of genes within the dorsal organiser region of the
amphibian embryo [47–49]. The large scale analysis of gene
expression provided by our microarray experiments show that
FGF signaling is required for the normal expression of a large
number of organizer genes, including goosecoid, chordin, noggin, dkk1
and Frzb, and a number of genes, such as Sip1 and FoxD5, which
are expressed in the dorsal neuroectoderm (See Table S14). Such a
role is very much in keeping with the observed activity of MAP
kinase signalling in the dorsal marginal zone and dorsal
neuroectoderm, and supports the view that FGF signaling is
required during late blastula and early gastrula stages for the
establishment of both the Spemann organizer and the presumptive
neuroectoderm.
There are also indications that FGF signaling is required to
negatively regulate and therefore restrict gene expression in the
dorsal region of the embryo. For example, the transcription factors
Hes1b is up regulated in response to FGF inhibition. We note that
Hes1b is expressed in the dorsal region of the gastrula but at some
distance from the highest levels of FGF activity in the blastopore
region [50]. It is also seems likely that negative regulation by FGF
restricts XANF1 expression to the deeper layers of the organizer
region in the early gastrula [51].
Gene function downstream of FGF signaling
A detailed description of the putative function for each of the
identified target genes is beyond the scope of this discussion and
we refer the reader to the extensive annotation and literature
resources provided in Tables S2, S3, S4, S5, S6, S7, S8, S9, S10
and S11.
A number of the genes identified in the screen are of unknown
function either because they are orthologs of genes with poorly
characterized function or because we were unable to identify
orthologous genes in the databases and may therefore represent
novel Xenopus genes. However, analysis of the annotated genes
identified in the screen reveals that a large proportion of the genes
regulated by FGF signaling, are themselves also involved in gene
regulation, either directly, as in the case of transcription factors, or
via involvement in other signaling pathways. This indicates the key
position of FGFs as upstream regulators of genetic pathways
leading to germ layer specification during the late blastula to early
gastrula stage of amphibian development. In addition, FGF
signaling is required for the normal expression of genes such as
Prickle, marginal coil and Ephrin receptor A4 (pagliaccio) which are
involved in regulating cell movements and adhesion during
gastrulation [52–54].
We also note that the purine phosphorylase and glycogen phosphorylase
genes, which code for enzymes involved in nucleotide and
carbohydrate metabolism respectively, are dependent on FGF
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domains in the early mesoderm. Further studies will be required to
determine if these genes have previously unsuspected roles in the
regulation of developmental mechanisms.
Previous studies have identified a number of FGF inducible
inhibitors of the FGF signaling pathway, including the Sprouty
genes, which we find are significantly down regulated in our screen
[36,55]. In the present study we identify the MAP kinase
phosphatase genes MKP1 and DUSP5 as FGF targets which are
activated rapidly following the mid-blastula transition and show
that they are able to inhibit FGF signalling in Xenopus tissues.
DUSP5 is a novel Xenopus MKP which is expressed in the early
mesoderm and neural plate in a pattern which is remarkably
similar to that of Xenopus FGF3 [44]. Similar correlation with sites
of FGF activity has been reported for MKP3, which has also been
shown to act as a feedback inhibitor of FGF signaling [34,56].
The picture that emerges is that activation of FGF signaling
induces the production of multiple inhibitors which act to
moderate and limit the response to FGF signaling. A number of
positive feedback mechanisms also impact on the FGF pathway,
including the transcriptional activation the FLRT3 and brachyury
genes [6,57,58]. FLRT3 is a transmembrane protein that
Figure 6. MKPs and FGF signalling. (A) shows the temporal expression profiles of MKP1, MKP3 and DUSP5 from blastula stage 8 until early neurula
stage 14 (5 to 16 hours pf at 23uC). Profiles are derived from normalised microarray expression levels. Relative expression values are represented as
percentages of the maximum expression value for each gene. (B) is a chart showing the expression of MKP1. MKP3 and DUSP5 in control embryos and
embryos injected with 4 ng dnFGFR1 mRNA or 4 ng dnFGFR4 mRNA. Microarray derived expression values are based on the average of three
biological replicates. Relative expression is calculated a percentage of the expression in control embryos. Experiments in (C, D and E) were carried out
on animal cap explants removed from blastula stage 8 embryos. In all cases control explants are from uninjected embryos, FGF4 treatment was with
10 units of recombinant protein and mRNA injections were with 10 ng MKP1, MKP3 or DUSP5. (C) shows the morphology of animal cap explants at
tailbud stage 41. (D) shows 10 mm histological sections of animal cap explants at stage 41. (E) is a Western blot showing levels of dp-ERK and the
loading control GAPDH in animal cap explants at stage 10.5.
doi:10.1371/journal.pone.0004951.g006
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transcription factor which has been shown to be a component of a
positive feedback loop that leads to increased transcription of FGF
ligand genes in the early mesoderm [5,6,58]. The presence of
positive and negative feedback loops which modulate FGF
signaling at multiple levels highlights the critical importance for
fine tuning the overall levels of FGF signaling during development.
An interesting observation is that expression of the FoxD3 and
Lin28 genes are down regulated in response to FGF inhibition. The
FoxD3 transcription factorislinked to amphibian organizer function
[59] but hasalsobeen implicatedasa component ofthe pluripotency
circuitofmammalianembryonicstemcellsviaregulationofthenanog
gene [17,18]. The Lin28 gene codes for an RNA binding protein,
which together with the Oct4, Sox2 and Nanog genes, can convert
somatic cells to an embryonic stem cell phenotype [14].
Previous studies have indicated that FGF signaling is required as
a competence factor necessary for the response of embryonic
amphibian cells to activin-like signals during development
[39,40,60]. We also note a recent study which showed that FGF
signaling in murine ES cells is necessary to allow differentiation
into multiple lineages, including mesoderm [12]. These observa-
tions raise the intriguing possibility that FGF signaling, acting via
downstream targets such as Lin28 and FoxD3, might have a general
role in regulating pluripotency or the competence of embryonic
cells to respond to signals which direct differentiation both during
normal development and in culture.
Materials and Methods
Ethics statement
All animal work was undertaken under a licence from the UK
Home Office.
Embryological methods
Embryos were staged according to Nieuwkoop and Faber [61].
Normal embryos were cultured in NAM/10. Injection of embryos
with synthetic mRNAs was carried out in 33% NAM+5% ficoll
(Sigma) at the 2 or 4-cell stage. Animal caps were explanted from
embryos in 50% NAM Recombinant FGF4 [43] treatment was in
50% NAM+ 5 mg/ml BSA.
Identification of Xenopus tropicalis full length clones
Clones containing full length coding region of X.tropicalis MKP1
(DUSP1/XCL100) (accession number AL967533) and DUSP5
(accession number AL648624) were identified using the peptide
sequence of X.laevis orthologues (accession numbers
NM_001088684 and BJ067398 respectively) and BLASTP on
the Sanger Institute X.tropicalis EST database (www.sanger.ac.uk/
Projects/X_tropicalis/).
mRNA synthesis
Capped mRNA was synthesised using the SP6 Megascript kit
(Ambion) and a modified protocol using a 1:10 ratio of GTP to
m7G(59)Gppp(59)G cap. All cDNAs used for mRNA were in either
pSP64t, Cs2+ or CS107 and were transcribed using SP6
polymerase. The dominant negative X.laevis FGFRI (dnFGFR1)
plasmid was a gift from Enrique Amaya [24]. The dominant
negative X.laevis FGFR4a (dnFGFR4) plasmid was a gift from
Harumasa Okamoto [25]. The X.laevis MKP3 (DUSP6/X17C)
plasmid was a gift from Bob Old [62].
In situ hybridisation
Embryos were fixed in MEMFA and in situ hybridizations were
carried out as per [63] with the modifications described in [64].
Details for in situ probe plasmids are shown in Table S15. The
sources of the plasmids, including Geneservice (www.geneservice.
co.uk) and the NIBB/NIG/NBRP X. laevis EST project (xeno-
pus.nibb.ac.jp) are indicated.
RNAase protection analysis
RNA extraction and RNAase protection analysis were carried
out according to the methods of Pownall et al. (1996). Data
relating to RNAase protection plasmids are shown in Table S16.
Whole-mount immunohistochemistry and Western
blotting
dp-ERK immunohistochemistry was carried out according the
methods of [22]. Western blot samples were homogenized in
PhosphoSafe (Novagen) extraction buffer per embryo. Following
centrifugation supernatants were subjected to SDS-PAGE. Gels
were blotted onto Immobilon-P (Millipore) transfer membrane.
Antibody concentrations were mouse anti-dp-ERK (Sigma),
1:8000, anti-phosphoSmad1/5/8 (NEB), 1:500, anti-GAPDH
(HyTest), 1:3000. 1:8,000, anti-GAPDH (HyTest), 1:1,000,000,
anti-mouse POD (Amersham), 1:3000 and anti-rabbit POD
(Amersham), 1;2000. Peroxidase activity was detected using BM
chemiluminescence blotting substrate (Roche) and Hyperfilm
(Amersham).
Embryos for microarray experiments
Embryos were injected with 4 ng of dnFGFR1 or dnFGFR4
mRNA and were collected with sibling controls at early gastrula
stage 10.5 (11 hours post-fertilization at 23uC). In order to enable
statistical analysis three biological replicates were produced by in
vitro fertilization from different pairs of male and female frogs.
Each replicate set comprised control, dnFGFR1 injected and
dnFGFR4 injected embryos. Before processing for microarray
analysis each replicate set was assessed for the effectiveness of FGF
signaling inhibition by analysing levels of dp-ERK and levels of the
known FGF targets Xbra, Cdx4 and myoD expression in sibling
embryos.
For the early developmental timecourse embryos from a single
mating were cultured at 23uC and collected at 5, 6, 7, 8, 9, 10, 11,
12, 13, 14, 15 and 16 hours post fertilization (NF stage 8, 8.5, 9,
9.5, 10, 10+, 10.5, 11, 12, 12.5, 13 and 14) for microarray analysis.
Sibling embryos were also collected at the same time points for
Western blot analysis of dp-ERK.
Preparation of total RNA for microarray analysis
Batches of 10 embryos were extracted in Tri-reagent according
manufacturer’s protocol (Sigma). RNA was precipitated using
isopropanol and cleaned up using the Qiagen RNeasy kit followed
by a lithium chloride precipitation. Quality of RNA was assessed
using the Agilent 2100 Bioanalyzer.
Preparation of labelled cRNA and chip hybridization
2 mg of total RNA was processed for the microarray by using
the Affymetrix GeneChip one-cycle target labelling kit (Affymetrix)
according to the manufacturer’s recommended protocols. The
quality and quantity of the resulting biotinylated cRNA was
determined by using NanoDrop ND 1000 (NanoDrop Technol-
ogies) and Agilent Bioanalyzer 2100 (Agilent Technologies).
Biotin-labelled cRNA samples were fragmented randomly to 35–
200 bp at 94uC in fragmentation buffer (Affymetrix) according to
the manufacturer’s recommended protocols and aliquots of the
fragmented cRNA were run on the Agilent 2100 Bioanalyzer to
assess the quality of the generated cRNA.
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hybridization buffer containing hybridization Control cRNA and
Control Oligo B2 (Affymetrix), before hybridization to GeneChipH
Xenopus laevis Genome Array for 16 h at 45uC. The arrays were
washed, stained, and scanned using the Affymetrix Model 450
Fluidics Station and Affymetrix Model 3000 scanner using the
manufacturer’s recommended protocols.
Microarray data analysis
Affymetrix microarray experiments were conducted in accor-
dance with the MIAME standards requirements [65]. Raw data
processing was performed by using the Affymetrix GCOS 1.2
software. After hybridization and scanning, probe cell intensities
were calculated and summarized for the respective probe sets by
means of the MAS5 algorithm. To compare the expression values
of the genes from chip to chip, global scaling was performed,
which resulted in the normalization of the trimmed mean of each
chip to a target intensity (TGT value) of 500 as per manufacturers
documentation. Each sample and hybridization underwent a
quality control evaluation checking for adequate scaling factors (1–
3 for all samples), percentage of probe sets reliably detected
(between 40–60% present call), and optimal 39/59 hybridization
ratios for the housekeeping genes (e.g., GAPDH), poly(A) spike-in
controls, and the prokaryotic controls (bioB, bioC, bioD and cre).
Data were imported into BRB ArrayTools software version
3.6.0 (http://linus.nci.nih.gov/BRB-ArrayTools.html). Imported
array data were filtered using the following criteria.
1) Spot filters- Threshold minimum value if spot intensity
below 5.
2) Normalization- Normalize (center) each array using
median over entire array.
3) Exclude a gene under any of the following condi-
tions- Percent of data missing or filtered out exceeds 50%
Percent of absent (i.e., Detection Call=A) data exceeds 50%
Scatterplots were generated using the phenotype averages tool
of BRB ArrayTools. Gene lists of FGF targets were generated
using the BRB between groups of arrays class comparison tool
(unpaired, two sample t-test with random variance model and
nominal significance level p=0.01). An additional filter excluded
genes with less than 2-fold difference from controls.
Temporal expression profiles for a given gene were generated in
Microsoft Excel by plotting relative expression at each time point
as a percentage of the maximum expression level within the time
course. Cluster analysis was undertaken using the BRB gene
cluster analysis tool (complete linkage and centred correlation).
The Affymetrix Cel files for all microarray experiments are
available at EMBL ArrayExpress, accession numbers E-MEXP-
2058 and E-MEXP-2059.
Target gene annotation
Target gene annotation was accomplished using a combination
of existing Affymetrix Gene array annotation and BLAST
searching of target sequences against Genbank, Swiss-prot (www.
ncbi.nlm.nih.gov/BLAST/) and NIBB/NIG/NBRP Xenopus laevis
EST project (xenopus.nibb.ac.jp) databases.
Supporting Information
Figure S1 Alignment of amphibian and human DUSP5 peptide
sequences. Alignment of the peptide sequences for human and
Xenopus tropicalis DUSP5 produced by the Clustal W method.
Identical residues are boxed in red
Found at: doi:10.1371/journal.pone.0004951.s001 (0.15 MB TIF)
Figure S2 Expression of FGF7, FGF10 and FGF20 during
amphibian development. In situ hybridisations for showing the
expression of FGF7 (A, B and C), FGF10 (D, E and F) and FGF20
(G) at the indicated stages. In situ hybridizations for FGF7 and
FGF10 are on Xenopus tropicalis embryos. In situ hybridization
for FGF20 is on a Xenopus laevis embryo. (A, C D, E and F) are
lateral views with anterior to the left and dorsal to the top. (B) is a
posterior view with dorsal to the top. (G) is a vegetal view with
dorsal to the top. (A and B) shows expression in the posterior
mesoderm and ectoderm (white arrow) around the closed
blastopore (bp). Expression is also detected in the anterior
endoderm (end). (C) shows expression in the branchial arch region
(bra). (D and E) show expression in a domain juxtaposed to the
anterior of the otic vesicle (otv, black arrow) and in the branchial
arch (bra) region. (F) shows expression in the tailbud (tlb). (G)
shows expression in the circumblastoporal region in a distinct
dorsal to ventral gradient. The dorsal blastopore lip (dbl) is
indicated.
Found at: doi:10.1371/journal.pone.0004951.s002 (1.81 MB
DOC)
Table S1 Genes differentially regulated in dnFGFR1 versus
dnFGFR4 injected embryos
Found at: doi:10.1371/journal.pone.0004951.s003 (0.03 MB
DOC)
Table S2 Genes positively regulated by FGF signaling involved
in transcriptional regulation
Found at: doi:10.1371/journal.pone.0004951.s004 (0.07 MB
DOC)
Table S3 Genes positively regulated by FGF signaling involved
in cell signalling
Found at: doi:10.1371/journal.pone.0004951.s005 (0.08 MB
DOC)
Table S4 Genes positively regulated by FGF signaling involved
in metabolism
Found at: doi:10.1371/journal.pone.0004951.s006 (0.04 MB
DOC)
Table S5 Genes positively regulated by FGF signaling of other
known function
Found at: doi:10.1371/journal.pone.0004951.s007 (0.05 MB
DOC)
Table S6 Genes positively regulated by FGF signaling of
unknown function
Found at: doi:10.1371/journal.pone.0004951.s008 (0.04 MB
DOC)
Table S7 Genes negatively regulated by FGF signaling involved
in transcriptional regulation
Found at: doi:10.1371/journal.pone.0004951.s009 (0.03 MB
DOC)
Table S8 Genes negatively regulated by FGF signaling involved
in cell signalling
Found at: doi:10.1371/journal.pone.0004951.s010 (0.03 MB
DOC)
Table S9 Genes negatively regulated by FGF signaling involved
in metabolism
Found at: doi:10.1371/journal.pone.0004951.s011 (0.03 MB
DOC)
Table S10 Genes negatively regulated by FGF signaling of other
known function
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DOC)
Table S11 Genes negatively regulated by FGF signaling of
unknown function
Found at: doi:10.1371/journal.pone.0004951.s013 (0.03 MB
DOC)
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